Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Adlai Nortye Group Ltd.
Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab
October 15, 2026
From
Adlai Nortye Group Ltd.
Via
GlobeNewswire
Tickers
ANL
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
September 30, 2026
From
Adlai Nortye Group Ltd.
Via
GlobeNewswire
Tickers
ANL
Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC
September 08, 2026
From
Adlai Nortye Group Ltd.
Via
GlobeNewswire
Tickers
ANL
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.